Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
Nicole Casadevall(Inserm), Patrick Mayeux(Université Paris Cité), Valérie Ugo(Inserm), Irène Teyssandier(Inserm), J Nataf(Hôtel-Dieu de Paris), Amir Kolta(Association pour l'Utilisation du Rein Artificiel dans la région Lyonnaise), P Martin-Dupont, Patrick A. Michaud(Institution de Lavigny), Bruno Varet(Université Paris Cité), Jean‐Jacques Kiladjian(Délégation Paris 5), B Viron(Hôpital Bichat-Claude-Bernard), T. Papo(Assistance Publique – Hôpitaux de Paris)
Cited by 1,239
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
|Blood|2008|568
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
|Haematologica|2009|316